242 related articles for article (PubMed ID: 9112978)
1. Local injections of corticotropin releasing factor reduce doxorubicin-induced acute inflammation in the eyelid.
McLoon LK; Wirtschafter J
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):834-41. PubMed ID: 9112978
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin chemomyectomy is enhanced when performed two days following bupivacaine injections: the effect coincides with the peak of muscle satellite cell division.
Nguyen LT; McLoon LK; Wirtschafter JD
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):203-6. PubMed ID: 9430564
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin protects the eyelid skin from injury after injection of doxorubicin.
McLoon LK; Ozel B; Wirtschafter J
Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1433-40. PubMed ID: 7775121
[TBL] [Abstract][Full Text] [Related]
4. Direct injection of liposome-encapsulated doxorubicin optimizes chemomyectomy in rabbit eyelid.
McLoon LK; Wirtschafter JD
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2561-7. PubMed ID: 10509650
[TBL] [Abstract][Full Text] [Related]
5. Doxil-induced chemomyectomy: effectiveness for permanent removal of orbicularis oculi muscle in monkey eyelid.
McLoon LK; Wirtschafter JD
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1254-7. PubMed ID: 11328736
[TBL] [Abstract][Full Text] [Related]
6. Verapamil substantially increases the chemomyectomy effect of doxorubicin injected into rabbit or monkey eyelid.
McLoon LK; Ekern M; Wirtschafter J
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3228-34. PubMed ID: 1399427
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin chemomyectomy in orbicularis oculi: increasing drug infiltration at the injection site.
McLoon LK; Wirtschafter JD
Curr Eye Res; 1996 Aug; 15(8):883-9. PubMed ID: 8921232
[TBL] [Abstract][Full Text] [Related]
8. Chemomyectomy of the orbicularis oculi muscles for the treatment of localized hemifacial spasm.
Wirtschafter JD
J Neuroophthalmol; 1994 Dec; 14(4):199-204. PubMed ID: 7881523
[TBL] [Abstract][Full Text] [Related]
9. Quantification of muscle loss in the doxorubicin-treated orbicularis oculi of the monkey. Effect of local injection of doxorubicin into the eyelid.
McLoon LK; Bauer G; Wirtschafter J
Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1667-73. PubMed ID: 1826675
[TBL] [Abstract][Full Text] [Related]
10. Reduction in vesicant-induced cellular inflammation and hyperalgesia by local injection of corticotropin releasing factor in rabbit eyelid.
McLoon LK; Sandnas AM; Nockleby KJ; Wirtschafter JD
Inflamm Res; 2002 Jan; 51(1):16-23. PubMed ID: 11845996
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin chemomyectomy: injection of monkey orbicularis oculi results in selective muscle injury.
McLoon LK; Wirtschafter J
Invest Ophthalmol Vis Sci; 1988 Dec; 29(12):1854-9. PubMed ID: 3192375
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm and hemifacial spasm.
Wirtschafter JD; McLoon LK
Ophthalmology; 1998 Feb; 105(2):342-6. PubMed ID: 9479297
[TBL] [Abstract][Full Text] [Related]
13. Acute morphologic changes in orbicularis oculi muscle after doxorubicin injection into the eyelid.
McLoon LK; Luo XX; Wirtschafter J
Muscle Nerve; 1993 Jul; 16(7):737-43. PubMed ID: 8505930
[TBL] [Abstract][Full Text] [Related]
14. Reduction in touch sensitivity and hyperinnervation in vesicant-injured rabbit eyelid by direct injection of corticotropin releasing factor.
Harrison AR; McLoon LK
Neurosci Lett; 2006 May; 400(1-2):30-4. PubMed ID: 16510247
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin does not spread systemically following a local injection into the eyelids of rabbits.
McLoon LK; Josephson K; Wirtschafter J
Curr Eye Res; 1999 Sep; 19(3):285-9. PubMed ID: 10487969
[TBL] [Abstract][Full Text] [Related]
16. Treatment of periorbital edema with human corticotropin-releasing factor after blepharoplasty.
Schendel SA; Stephanides M
J Am Coll Surg; 1996 Mar; 182(3):226-32. PubMed ID: 8603242
[TBL] [Abstract][Full Text] [Related]
17. Regional differences in the subacute response of rabbit orbicularis oculi to bupivacaine-induced myotoxicity as quantified with a neural cell adhesion molecule immunohistochemical marker.
McLoon LK; Wirtschafter J
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3450-8. PubMed ID: 8225879
[TBL] [Abstract][Full Text] [Related]
18. Severe but temporary injury to rabbit orbicularis oculi muscle using dihematoporphyrin ether and laser photochemomyectomy.
Wirtschafter JD; Slovut DP; Stordal L; Valentino J; McLoon LK
Mov Disord; 1992; 7(2):171-7. PubMed ID: 1533899
[TBL] [Abstract][Full Text] [Related]
19. Protective actions of corticotropin-releasing factor on thermal injury to rat pawskin.
Wei ET; Serda S; Tian JQ
J Pharmacol Exp Ther; 1988 Dec; 247(3):1082-5. PubMed ID: 3264573
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
